Literature DB >> 12876231

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts.

W Hamel1, U Fietzek, A Morsnowski, B Schrader, J Herzog, D Weinert, G Pfister, D Müller, J Volkmann, G Deuschl, H M Mehdorn.   

Abstract

BACKGROUND: The subthalamic nucleus is the preferred target for deep brain stimulation in patients with advanced Parkinson's disease. The site of permanent stimulation is the subject of ongoing debate, as stimulation both within and adjacent to the subthalamic nucleus may be effective.
OBJECTIVE: To assess the position of active electrode contacts in relation to the dorsal margin of the subthalamic nucleus as determined by intraoperative microrecordings and magnetic resonance imaging (MRI).
METHODS: In 25 patients suffering from severe levodopa sensitive parkinsonism, deep brain stimulating electrodes (n = 49) were implanted following mapping of the subthalamic nucleus by microrecording and microstimulation along five parallel tracks. Postoperative stereotactic radiography and fusion of pre- and postoperative MRI studies were used to determine the stereotactic position relative to the midcommissural point of the most effective electrode contacts selected for permanent stimulation (n = 49). Intraoperative microrecordings were analysed retrospectively to define the dorsal margin of the subthalamic nucleus. In cases where the dorsal margin could be defined in at least three microrecording tracks (n = 37) it was correlated with the position of the active contact using an algorithm developed for direct three dimensional comparisons.
RESULTS: Stimulation of the subthalamic nucleus resulted in marked improvement in levodopa sensitive parkinsonian symptoms and levodopa induced dyskinesias, with significant improvement in UPDRS III scores. In several instances, projection of the electrode artefacts onto the T2 weighted MRI visualised subthalamic nucleus of individual patients suggested that the electrodes had passed through the subthalamic nucleus. When the actual position of active electrode contacts (n = 35) was correlated with the dorsal margin of the subthalamic nucleus as defined neurophysiologically, most contacts were located either in proximity (+/- 1.0 mm) to the dorsal border of the subthalamic nucleus (32.4%) or further dorsal within the subthalamic region (37.8%). The other active contacts (29.7%) were detected within the dorsal (sensorimotor) subthalamic nucleus. The average position of all active contacts (n = 49) was 12.8 mm (+/- 1.0) lateral, 1.9 mm (+/- 1.4) posterior, and 1.6 mm (+/- 2.1) ventral to the midcommissural point.
CONCLUSIONS: Subthalamic nucleus stimulation appears to be most effective in the border area between the upper subthalamic nucleus (sensorimotor part) and the subthalamic area containing the zona incerta, fields of Forel, and subthalamic nucleus projections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876231      PMCID: PMC1738607          DOI: 10.1136/jnnp.74.8.1036

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  63 in total

Review 1.  Which elements are excited in electrical stimulation of mammalian central nervous system: a review.

Authors:  J B Ranck
Journal:  Brain Res       Date:  1975-11-21       Impact factor: 3.252

2.  Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei.

Authors:  X L Zhu; W Hamel; B Schrader; D Weinert; J Hedderich; J Herzog; J Volkmann; G Deuschl; D Müller; H M Mehdorn
Journal:  Acta Neurochir (Wien)       Date:  2002-10       Impact factor: 2.216

3.  Further definition of the subthalamic target for arrest of tremor.

Authors:  F C Velasco; P Molina-Negro; C Bertrand; J Hardy
Journal:  J Neurosurg       Date:  1972-02       Impact factor: 5.115

4.  Subthalamotomy in Parkinson's disease.

Authors:  J Hullay; J Velok; R Gombi; G Boczàn
Journal:  Confin Neurol       Date:  1970

5.  Stereotaxic interventions on the zona incerta area for treatment of extrapyramidal motor disturbances and their results.

Authors:  F Mundinger
Journal:  Confin Neurol       Date:  1965

6.  Experiences with subthalamic lesions in patients with movement disorders.

Authors:  J L Story; L A French; S N Chou; M J Meier
Journal:  Confin Neurol       Date:  1965

7.  Pallido-thalamic mechanisms in movement disorders.

Authors:  R N Kjellberg
Journal:  Confin Neurol       Date:  1965

8.  Movement-related neurons of the subthalamic nucleus in patients with Parkinson disease.

Authors:  Aviva Abosch; William D Hutchison; Jean A Saint-Cyr; Jonathan O Dostrovsky; Andres M Lozano
Journal:  J Neurosurg       Date:  2002-11       Impact factor: 5.115

9.  Dyskinesias and grip control in Parkinson's disease are normalized by chronic stimulation of the subthalamic nucleus.

Authors:  Roland Wenzelburger; Bao-Rong Zhang; Meike Poepping; Bettina Schrader; Dieter Müller; Florian Kopper; Urban Fietzek; Hubertus M Mehdorn; Günther Deuschl; Paul Krack
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

View more
  40 in total

1.  Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson's disease.

Authors:  Paul Sauleau; Sylvie Raoul; François Lallement; Isabelle Rivier; Sophie Drapier; Youenn Lajat; Marc Verin
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

2.  Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts.

Authors:  F Godinho; S Thobois; M Magnin; M Guenot; G Polo; I Benatru; J Xie; A Salvetti; L Garcia-Larrea; E Broussolle; P Mertens
Journal:  J Neurol       Date:  2006-06-20       Impact factor: 4.849

Review 3.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

4.  Current steering to control the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2008-01       Impact factor: 8.955

5.  Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes.

Authors:  C B Maks; C R Butson; B L Walter; J L Vitek; C C McIntyre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-10       Impact factor: 10.154

6.  Suppression of EEG visual-evoked potentials in rats through neuromodulatory focused ultrasound.

Authors:  Hyungmin Kim; Michael Y Park; Stephanie D Lee; Wonhye Lee; Alan Chiu; Seung-Schik Yoo
Journal:  Neuroreport       Date:  2015-03-04       Impact factor: 1.837

7.  Imaging for deep brain stimulation: The zona incerta at 7 Tesla.

Authors:  Hans U Kerl; Lars Gerigk; Marc A Brockmann; Sonia Huck; Mansour Al-Zghloul; Christoph Groden; Thomas Hauser; Armin M Nagel; Ingo S Nölte
Journal:  World J Radiol       Date:  2013-01-28

8.  Relative contributions of local cell and passing fiber activation and silencing to changes in thalamic fidelity during deep brain stimulation and lesioning: a computational modeling study.

Authors:  Rosa Q So; Alexander R Kent; Warren M Grill
Journal:  J Comput Neurosci       Date:  2011-10-05       Impact factor: 1.621

9.  Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease.

Authors:  Andrew Sharott; Alessandro Gulberti; Simone Zittel; Adam A Tudor Jones; Ulrich Fickel; Alexander Münchau; Johannes A Köppen; Christian Gerloff; Manfred Westphal; Carsten Buhmann; Wolfgang Hamel; Andreas K Engel; Christian K E Moll
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

10.  Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease.

Authors:  Andrew I Yang; Nora Vanegas; Codrin Lungu; Kareem A Zaghloul
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.